Genomics In Cancer Care Market Overview
All living things like humans, animals, multi-cellular plants, single-celled bacteria have a genome. Genomics is the study of organism’s genome, genetic material and applied information. Genomics helps in studying the total genetic sequence information of organisms and understanding structure & function of sequences of downstream biological products. Whole genome sequencing test used in determining higher risk of developing cancer in human being. Genomics helps clinicians in providing oncology treatments for patients and also helps in detecting resistance to therapies. Genomics enables early diagnosis. Cancer genomics has become very important which has improved understanding of biology of cancer and provides new methods of diagnosing & treating disease. Genomic researchers analyze DNA sequence data which helps in finding variations affecting health, drug response and disease. Damage to DNA in cells causes cancer. Change in gene is called mutation. Therefore, study of genomics has become important in diagnosing and treating cancer disease. US National Cancer Institute (NCI) has sequenced more than 20,000 primary cancer samples of 33 types of cancer in ‘The Cancer Genome Atlas Programme’. Metagenomics is an important application of genomics. Metagenomics used to identify and study micro-organisms within habitat. Metagenomics used in determining the interactions between host & bacteria. Wide applications and importance of genomics in cancer study has given positive impact on Genomics in Cancer Care Market growth.
|
Attributes |
Details |
|
Genomics in Cancer Care Market Value (2022) |
US$ 16.1 Bn |
|
Genomics in Cancer Care Market Projected Value (2032) |
US$ 72.61 Bn |
|
Genomics in Cancer Care Market CAGR (2022 – 2032) |
16.3% |
Genomics In Cancer Care Market Dynamics
Emerging clinical relevance of genomics in cancer
Rise in clinical relevance of genomics in cancer is one of the leading factors for the Global Genomics in Cancer Care Market growth. The application of next generation sequencing (NGS), to cancer genomics discovery at large scale has revealed new extraordinary information about genomic drivers in development of cancer & progression across different anatomical locations. Rise in genomic based assays used in selection of targeted therapies according to genome of the tumors & non-malignant cells. Genomics-based assays are potential in use of immunotherapeutic agents by broadening clinical applicability. Genomic alterations helps in revealing individual targetable alterations, tumor-specific antigens, complex mutation signatures and mutational load which will help in informing personalized anticancer vaccines, immune-checkpoint inhibitors and utilization of targeted therapies. Genomic assays are giving rise in providing information pertinent to clinical cancer care. Rise in genomics-based assays in diagnosis has become helpful in informing patient care with cancer. Emerging applications is expected to expand the use of next generation sequencing based diagnostic in cancer medicine. For instance, in 2018 (PMC), increasing clinical relevance or applications of genomics in cancer medicine includes characterizing mechanism of resistance and monitoring treatment response in patients. Development of targeted small molecule & antibody-based therapies which target cancer genome has fuelled use of genomic assays in cancer patients. However, emerging applications of genomics in cancer has boost the Genomics in Cancer Care Market growth.
Recent advancement in genomic medicine
Recent advancement in cancer genomics has become the major factor in target market growth. Advancement in Genomic medicine are expected to transform pathway of every aspect of cancer patients. Advancement in Genomic medicine has revolutionized cancer patient care by driving clinical practice of precision oncology. Advancement in cancer pharmacogenomics and “omics” technology has provide tremendous potential in optimizing cancer patient care. Advancement in genetic technology has offered major impact in clinic and change in genetic testing. Advancement in genetic technology has brought greater opportunities in diagnosis of cancer and uncertain findings which may help in earlier treatment of an individual. For instance, in 2019, (PMC), it was determined that recent development in genetic technology has given positive and big impact on cancer patient care providing great potential in improving health. However, recent advancement in genomic medicine has fuelled the Genomics in Cancer Care Market growth.
Restrains:
However, genetic screening for cancer may cause stress & anxiety in some individuals. Genomics in cancer treatment helps in studying and providing diagnostic treatment for cancer patients but does not reduce the risk for cancer in individual. Results after genomic testing may be uncertain or inconclusive. Lack of skilled personnel, expensive cost, limited access to genomic data tools, and psychological stress during genomic testing may somewhat restrain the Genomics in Cancer Care Market growth.
Genomics In Cancer Care Market Segmentation
Global Genomics in Cancer Care Market is segmented based on type, application, end-user and region.
Type Insight
On the basis of Type Global Genomics in Cancer Care Market is segmented into Structural Genomics and Functional Genomics. Structural Genomics includes sequencing, mapping of genomes and physical nature of genome. Functional Genomics includes study of expression of genome and function of genome.
Application Insights
On the basis of Application Global Genomics in Cancer Care Market is segmented into Gene Therapy, Gene Discovery, Personalized Medicine, Pharmacogenetics & Targeted Therapy, Metagenomics, Mitochondrial Genomics, Pharmacogenomics, and other. Metagenomics has dominated the market because of its important application of genomics like study of all micro-organisms, potential in discovering new genes & proteins, and better accuracy. In 2020, application of metagenomics has used in exploring and developing novel enzymes from nature because metagenomics allows researchers to obtain data on genes coding enzyme and microbial diversity.
End-User
On the basis of End-User Global Genomics in Cancer Care Market is segmented into Research Institute, Hospitals, Academic Research Institutes, Diagnostic Centers, and others. Diagnostic Centers has dominated the market due to rising of cancer disease, awareness among people in earlier diagnose and rising demand for rapid & accurate results.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
On region the Global Genomics in Cancer Care Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, rising awareness in individual pertaining to cancer genomics, rapid growth in biotechnology industries, diagnostic centers, is anticipated to increase demand for Genomics in Cancer Care in the region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2022 |
|
Forecast period |
2022 – 2032 |
|
Market representation |
Revenue in USD Billion & CAGR from 2022 to 2032 |
|
Market Segmentation |
By Type - Structural Genomics, Functional Genomics By Application - Gene Therapy, Gene Discovery, Personalized Medicine, Pharmacogenetics & Targeted Therapy, Metagenomics, Mitochondrial Genomics, Pharmacogenomics, and others By End-User - Research Institute, Hospitals, Academic Research Institutes, Diagnostic Centers, and others
|
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Global Genomics in Cancer Care Market report based on type, application, end-user and region:
Global Genomics in Cancer Care Market, By Type:
- Structural Genomics
- Functional Genomics
Global Genomics in Cancer Care Market, By Application:
- Gene Therapy
- Gene Discovery
- Personalized Medicine
- Pharmacogenetics & Targeted Therapy
- Metagenomics
- Mitochondrial Genomics
- Pharmacogenomics
- Others
Global Genomics in Cancer Care Market, By End-User:
- Research Institute
- Hospitals
- Academic Research Institutes
- Diagnostic Centers
- Others
Global Genomics in Cancer Care Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Genomics In Cancer Care Market Key Players
The key players operating the Global Genomics in Cancer Care Market includes,
Pacific Biosciences Inc.
It is an American Biotechnology Company. It is the developer and manufacturer of systems for gene sequencing.
Abbott Molecular Oxford Gene Technology
It provides molecular intelligence for personalized healthcare. It offers automation and assays for oncology, infectious disease and genetics.
Roche Diagnostics
It offers in-vitro diagnostic solutions, tissue diagnostics, molecular diagnostics, immunoassays, clinical chemistry, next-generation sequencing, point of care testing and other.
Bio-Rad Labs
It provides technical resources for laboratory quality control workflow. It also manufactures proteomics, genomics, clinical diagnostic products for industrial, medical, research institutes, etc.
Illumina Inc.
It offers innovative array-based solutions for protein analysis, RNA, DNA, serve tools for drug development, disease research and other.
Quest Diagnostics
It offers international and domestic testing services which includes drug screening, clinical trials, complex testing, and other.
Beckman Coulter Inc.
It offers clinical diagnostic products like lab automation, cell counting, TOC analysis, flow cytometry, centrifugation and other.
Intrexon Bioinformatics Germany GmbH
It offers bio-informatics software solutions.
Agilent Technologies
It offers scientific solutions. It provides lab instruments, software services, etc.
PerkinElmer
It is an American global corporation in business areas like life-science research, diagnostics, and other.
Danaher Corporation
It is the innovator in science & technology and offers lab instruments like cell counter, air particle counter and other.
Cancer Genetics Inc.,
It is an emerging leader in personalized medicine, oncology diagnostics, etc.
Thermo Fisher Scientific Inc.,
It is an American supplier of scientific instrumentation, software services, reagents and other.
Recent Development
- In April 2021, Pacific Biosciences Inc., has launched new improved HiFi Sequencing and Software v10.1. This newly launched software has increased number of HiFi reads about 99.9% accuracy (QV30) has application in whole genome sequencing. These highly accurate long read provides deeper biological insight in genome. It includes faster polymerase with improving data quality.
- In September 2022, Thermo Fisher Scientific Inc., has launched new CE-IVD (IVDD) Oncomine Dx Express Test & Oncomine Reporter Dx informatics combined with Ion Torrent Genexus Dx System for delivering clinically relevant biomarker results in little time. This new next-generation sequencing test and analysis software has developed to expand the access in precision oncology biomarker testing.
Genomics In Cancer Care Market Company Profile
- Pacific Biosciences Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott Molecular Oxford Gene Technology
- Roche Diagnostics
- Bio-Rad Labs
- Illumina Inc.
- Quest Diagnostics
- Beckman Coulter Inc.
- Intrexon Bioinformatics Germany GmbH
- Agilent Technologies
- PerkinElmer
- Danaher Corporation
- Cancer Genetics Inc.
- Thermo Fisher Scientific Inc.*
“*” marked represents similar segmentation in other categories in the respective section
Genomics In Cancer Care Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Genomics in Cancer Care Market, By Type
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Structural Genomics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Functional Genomics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Genomics in Cancer Care Market, By Application, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Gene Therapy
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Gene Discovery
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Personalized Medicine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Pharmacogenetics & Targeted Therapy
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Metagenomics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Mitochondrial Genomics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Pharmacogenomics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Genomics in Cancer Care Market, By End-User, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Research Institute
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Academic Research Institutes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Diagnostic Centers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Genomics in Cancer Care Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Overview
-
-
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
-
-
-
-
- GCC
- Israel
- South Africa
- Rest of Middle East
-
-
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Pacific Biosciences Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott Molecular Oxford Gene Technology
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Rad Labs
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Illumina Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Quest Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Beckman Coulter Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Intrexon Bioinformatics Germany GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Agilent Technologies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- PerkinElmer
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Danaher Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cancer Genetics Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Genomics in Cancer Care Market is segmented into, type, application, end-user and region.
Genomics in Cancer Care Market is driven by factors like emerging clinical relevance of genomics in cancer, and recent advancement in genomic medicine.
By region, the Genomics in Cancer Care Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements.
The key players operating the Genomics in Cancer Care Market includes, Pacific Biosciences Inc., Abbott Molecular Oxford Gene Technology, Roche Diagnostics, Bio-Rad Labs, Illumina Inc., Quest Diagnostics, Beckman Coulter Inc., Intrexon Bioinformatics Germany GmbH, Agilent Technologies, PerkinElmer, Danaher Corporation, Cancer Genetics Inc., Thermo Fisher Scientific Inc., and others.